Cargando…
The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients
Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency is now performed in an increasing number of countries all over the world. The main goal of the screening is to achieve early diagnosis and treatment in order to prevent neonatal salt-crisis and death. The screenin...
Autores principales: | Lajic, Svetlana, Karlsson, Leif, Zetterström, Rolf H., Falhammar, Henrik, Nordenström, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569867/ https://www.ncbi.nlm.nih.gov/pubmed/33117907 http://dx.doi.org/10.3390/ijns6030068 |
Ejemplares similares
-
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020) -
Long-Term Outcomes of Congenital Adrenal Hyperplasia
por: Nordenström, Anna, et al.
Publicado: (2022) -
Very long‐chain acyl‐CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics
por: Olsson, David, et al.
Publicado: (2022) -
The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia
por: Ekbom, Kerstin, et al.
Publicado: (2022) -
Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH
por: Wallensteen, Lena, et al.
Publicado: (2020)